Economy

Stifel Nicolaus Keeps a Buy Rating on SAGE Therapeutics

Stifel Nicolaus Keeps a Buy Rating on SAGE Therapeutics”

They now have a United States dollars 81 price target on the stock. The biopharmaceutical company reported ($1.88) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($1.63) by ($0.25). On Tuesday, May 24 the stock rating was initiated by Chardan Capital Markets with "Sell". Gemmer Asset Mngmt Ltd Co owns 0% invested in Resources Connection, Inc. It has outperformed by 3.59% the S&P500. In analysts report revealed to investors on 14 September, BMO Capital maintained their Outperform rating on shares of SAGE. (SAGE) by 68.34% based on its latest 2016Q4 regulatory filing with the SEC.

In the transaction dated November 11, 2016, the great number of shares disposed came courtesy the CFO, Secretary and Treasurer; Iguchi Kimi disposed a total of 1,500 shares at an average price of $50.59, amounting to approximately $75,885. Bamco owns 88,320 shares. Chardan Capital Markets upgraded SAGE Therapeutics Inc (NASDAQ:SAGE) rating on Tuesday, February 14. (SAGE) was down -7.89% during the last trading session, with a day high of 77.89. SAGE Therapeutics Inc (NASDAQ:SAGE) has risen 116.45% since September 15, 2016 and is uptrending. It has outperformed by 99.75% the S&P500. Also, there are 1 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.45 average brokerage recommendation. Its down 0.13, from 1.11 in 2016Q3. It fall, as 17 investors sold SAGE shares while 41 reduced holdings. Dynamic Technology Lab Private Ltd raised its stake in Sage Therapeutics by 164.4% in the second quarter. 1,363,317 shares of the company were exchanged. The Florida-based Raymond James & Associates has invested 0% in SAGE Therapeutics Inc (NASDAQ:SAGE). Schwab Charles Investment Management Inc reported 129,847 shares. Invesco accumulated 1.34M shares. State Street Corp now owns 1,212,384 shares of the biopharmaceutical company's stock valued at $96,558,000 after acquiring an additional 87,097 shares during the last quarter. Dupont Cap Mngmt holds 13,528 shares or 0.02% of its portfolio. "(SAGE) Receives Buy Rating from SunTrust Banks, Inc." was first reported by TrueBlueTribune and is the property of of TrueBlueTribune. Eagle Asset Management owns 110,376 shares for 0.04% of their portfolio. Putnam Invs has 8,624 shares. Driehaus Management Ltd has invested 0.04% in SAGE Therapeutics Inc (NASDAQ:SAGE). Northern Tru holds 341,534 shares. Moreover, Mirae Asset Glob Com Limited has 0.02% invested in SAGE Therapeutics Inc (NASDAQ:SAGE).

Media coverage about Sage Therapeutics (NASDAQ:SAGE) has been trending somewhat positive on Wednesday, Accern Sentiment reports.

Among 14 analysts covering SAGE Therapeutics (NASDAQ:SAGE), 11 have Buy rating, 0 Sell and 3 Hold. Therefore 79% are positive. The stock now has an average rating of "Buy" and a consensus price target of $78.14. Cowen and Company reduced their target price on shares of Sage Therapeutics from $100.00 to $90.00 and set an outperform rating for the company in a report on Tuesday. H.C. Wainwright downgraded the shares of SAGE in report on Wednesday, February 22 to "Neutral" rating. BMO Capital Markets initiated the shares of SAGE in report on Wednesday, June 29 with "Outperform" rating. The stock of SAGE Therapeutics Inc (NASDAQ:SAGE) earned "Buy" rating by Leerink Swann on Tuesday, June 20. (NASDAQ:SAGE), with 8 analysts believing it is a strong buy. H.C. Wainwright maintained SAGE Therapeutics Inc (NASDAQ:SAGE) rating on Friday, August 4. Robert W. Baird maintained Resources Connection, Inc. H.C. Wainwright has "Hold" rating and $8600 target.

09/12/2017 - Sage Therapeutics, Inc. had its "buy" rating reiterated by analysts at Stifel Nicolaus. During the same period in the prior year, the firm posted ($1.08) EPS. 2951985 shares were traded on Sage Therapeutics, Inc.'s last session.

Goldman Sachs Group Inc stated it has 0% of its portfolio in SAGE Therapeutics Inc (NASDAQ:SAGE).

Analysts await Qiagen NV (NASDAQ:QGEN) to report earnings on November, 1. Sage Therapeutics earned a news impact score of 0.11 on Accern's scale.

Analysts await Resources Connection, Inc. They expect $0.56 earnings per share, up 230.23% or $0.99 from last year's $-0.43 per share. ACY's profit will be $793,152 for 5.74 P/E if the $0.56 EPS becomes a reality. After $0.20 actual EPS reported by Resources Connection, Inc. for the previous quarter, Wall Street now forecasts -40.00% negative EPS growth.

Among 2 analysts covering Resources Connection Inc. (NYSE:V), 27 have Buy rating, 0 Sell and 5 Hold. Therefore 0 are positive. Visa Inc. has $122.0 highest and $70 lowest target. Qiagen had 19 analyst reports since August 3, 2015 according to SRatingsIntel. On Thursday, August 3 the stock rating was maintained by Cowen & Co with "Buy". The stock of Visa Inc (NYSE:V) earned "Buy" rating by Bank of America on Friday, July 21. The firm has "Hold" rating given on Thursday, November 12 by Stifel Nicolaus. The firm has "Buy" rating given on Thursday, December 17 by Sterne Agee CRT.



Like this

Latest


15 September 2017
Credo set to receive federal funding to help fight opioid epidemic
NY received the aid from the Substance Abuse and Mental Health Services Administration, an agency within the U.S. The funding will also go towards statewide prevention and recovery programs.

15 September 2017
Prudential Financial (PRU) Earns Daily Coverage Optimism Score of 0.25
The stock of Interrent Real Estate Investment Trust (TSE:IIP.UN) has "Hold" rating given on Tuesday, November 8 by TD Securities. The disclosure for this sale can be found here. 222,857 shares valued at $24.08M were sold by Lowrey Charles F on Monday, May 8.

15 September 2017
Spotify's New iMessage App Makes it Easier to Text Songs to Friends
You might be accustomed to sharing Spotify tracks while you're in the music app and sending it to someone through iMessage. If they're a Spotify member, they'll also see a little Spotify icon in the upper left corner of the iMessage screen.

15 September 2017
AXA Explores Options For European Asset Management Unit
Shares in Natixis and Axa both declined by roughly 1 percent in mid-morning trading on September 15. AXA Investment Management, the company's investment arm, has £651 billion of AUM.

15 September 2017
Royal Caribbean Cruises' (RCL) Buy Rating Reaffirmed at Stifel Nicolaus
Zacks Investment Research has downgraded Royal Caribbean Cruises Ltd (NYSE:RCL) to Hold in a statement released on 06/21/2017. After $0.46 actual EPS reported by Bank of America Corp for the previous quarter, Wall Street now forecasts 2.17% EPS growth.

15 September 2017
Vikings have 'guarded optimism' but still concerned about Sam Bradford's knee
It is the same knee that underwent ACL repairs in 2013 and 2014 when Bradford was with the Rams. Zimmer then corrected himself, saying, "I anticipate that he will, yes".

15 September 2017
National Basketball Association expected to vote on draft lottery reform
Under the recommended plan for the Draft, the odds of getting the No. 1 pick would be smoothed out for the League's worst teams. Having the worst record possible gives that franchise the best chance at landing the first overall pick in the following draft.

15 September 2017
Analyst Opinion Summary: Hewlett Packard Enterprise Company (HPE), KB Home (KBH)
Finally, Pzena Investment Management LLC boosted its position in shares of Hewlett Packard Enterprise by 27.7% in the 2nd quarter. The firm owned 210,038 shares of the technology company's stock after acquiring an additional 194,880 shares during the period.

15 September 2017
'The Crown' Star Claire Foy Is Your New Lisbeth Salander
Then, Craig will soon dive into his final go-around as James Bond in Bond 25 and Mara has no shortage of films on her plate. David Lagencrantz took over as the new author starting with the fourth installment, The Girl in the Spider's Web .

15 September 2017
Judge sets date for Cosby retrial on sexual assault charges
Cosby will go to trial with a new team of lawyers because his attorneys in the first trial have withdrawn from the case. O'Neill says the new trial will begin April 2, 2018 at nine a.m.in the Montgomery County Courthouse.